Markus D. Siegelin - Concepedia

Author

Markus D. Siegelin

Columbia University Irving Medical Center ORCID

Also Known As

M D Siegelin, M SIEGELIN, M Siegelin, M. D. Siegelin, M. Siegelin, M.D. Siegelin, Markus D Siegelin, Markus D. Siegelin, Markus David Siegelin, Markus Siegelin

239

Publications

6.9K

Citations

H-Index

Concepts

All Affiliations

Columbia University Irving Medical Center Universität Ulm Heidelberg University Columbia University University Hospital Heidelberg

About

Markus D. Siegelin is an author at Columbia University Irving Medical Center specializing in medicine, tumor biology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	41	2.3K
2	Cell Biology	22	29	1.4K
3	Health Sciences	5	5	223
4	Social Sciences	4	4	233
5	Natural Sciences	1	1	193

Markus D. Siegelin

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models Trang Nguyen, Yiru Zhang, Enyuan Shang, Journal of Clinical Investigation	2020	198
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis Jana Biermann, Johannes C. Melms, Amit Dipak Amin, Cell Neuro-oncologyMelanomaTreatment-naive EcosystemNeuroscienceMedicine	2022	194
Heat Shock Protein 60 Regulation of the Mitochondrial Permeability Transition Pore in Tumor Cells Jagadish C. Ghosh, Markus D. Siegelin, Takehiko Dohi, Cancer Research MitophagyTumor MaintenanceApoptosisMitochondrial Permeability TransitionMolecular Biology	2010	193
Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism Pavan S. Upadhyayula, Dominique Higgins, Angeliki Mela, Nature Communications	2023	162
Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells Markus D. Siegelin, Takehiko Dohi, Christopher M. Raskett, Journal of Clinical Investigation	2011	155
Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up Timo Gaiser, Heinz Kutzner, Gabriele Palmedo, Modern Pathology Surgical PathologyHistopathologyMelanomaPathologyAmbiguous Melanocytic Lesions	2010	135
Quercetin promotes degradation of survivin and thereby enhances death-receptor–mediated apoptosis in glioma cells Markus D. Siegelin, Antje Habel, Abdelhaq Rami, Neuro-Oncology Molecular PharmacologyFlavonoid QuercetinChemoprevention StrategyGliomaQuercetin Exposure	2008	135
Insulin-Resistant Brain State after Intracerebroventricular Streptozotocin Injection Exacerbates Alzheimer-like Changes in Tg2576 AβPP-Overexpressing Mice Konstanze Plaschke, Juergen Kopitz, Markus D. Siegelin, Journal of Alzheimer s Disease Tg2576 Aβpp-overexpressing MiceTau ProteinSocial SciencesIntracerebroventricular Streptozotocin InjectionAlzheimer's Disease	2010	120
Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL Georg Karpel‐Massler, Chiaki Tsuge Ishida, Elena Bianchetti, Nature Communications	2017	114
Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy Jagadish C. Ghosh, Markus D. Siegelin, Valentina Vaira, JNCI Journal of the National Cancer Institute	2015	107

Page 1